Company Alliqua Biomedical Inc Nasdaq
Equities
US0196213096
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Julien Mamet
FOU | Founder | - | 07-09-30 |
Rick Orr
CEO | Chief Executive Officer | - | 10-11-30 |
Dina Gonzalez
DFI | Director of Finance/CFO | - | 09-12-31 |
William Martin
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eckard Weber
BRD | Director/Board Member | 73 | - |
Stanley Abel
BRD | Director/Board Member | - | 07-12-31 |
Dennis Podlesak
CHM | Chairman | 66 | - |
Rick Orr
CEO | Chief Executive Officer | - | 10-11-30 |
Matthew Ruth
BRD | Director/Board Member | - | 19-05-05 |
Julien Mamet
FOU | Founder | - | 07-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,807,877 | 5,807,877 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Adynxx, Inc.
100 Pine Street Suite 500
94111, San Francisco
+
![address Alliqua Biomedical Inc](https://cdn.zonebourse.com/static/address/38065916.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+24.99% | 46.56B | |
+45.38% | 41.67B | |
+0.19% | 41.16B | |
+33.14% | 32.4B | |
+20.93% | 28.18B | |
-6.35% | 28.1B | |
+48.82% | 14.52B | |
+47.12% | 13.74B | |
+3.28% | 12.17B |